Anthropic research reveals AI models perform worse with extended reasoning time, challenging industry assumptions about test-time compute scaling in enterprise deployments.

In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...